ESR1 and breast cancer: However, numerous studies have confirmed that long-term use of hormone replacement or selective estrogen receptor modulators will increase the risk of breast cancer, cardiovascular disease, venous thrombosis, and other diseases, so it is not suitable for long-term clinical application [33, 34].